The International Agency for Research on Cancer (IARC) estimates that globally, one in 5 persons create cancer in the course of their lifetime, and one in eight guys and one in 11 females die from the illness. These new estimates recommend that more than 50 million persons are living inside 5 years of a previous cancer diagnosis. According to GLOBOCAN 2020 database (an on line resource that delivers worldwide cancer statistics and estimates of incidence and mortality in 185 nations for 36 varieties of cancer) released by IARC, India sees a 5-year survival price of about 30% of cancer patients. Early detection and early therapy with the enable of common screening plays a very important function in stopping and enhancing the survival price of cancer patients in the nation.
“Screening helps healthy, asymptomatic people identify previously unrecognised health risks at an early stage, allowing them to modify their lifestyle and prevent lifestyle diseases and in case of cancers, gives them the best chance of receiving effective treatment,” says Mohamed Kasim, president, Dr Kutty’s Healthcare, a rapid-developing healthcare business.
Recently, the Japanese intelligent imaging and health-related technologies significant Fujifilm and Dr Kutty’s Healthcare joined hands to set up ‘NURA’—their very first well being-screening centre in the nation, in Bengaluru. “With this examination centre, we aim to create awareness and an environment of opting for regular medical screening and taking preemptive healthcare measures,” says Kasim.
Equipped with the very best of Artificial Intelligence (AI) enabled imaging and specialist healthcare, NURA centre can properly test 10 prevalent cancers, like oral cancer, breast cancer, cervical cancer, lung cancer, stomach cancer, colon cancer, prostate cancer, esophageal cancer, laryngeal cancer and early indicators of leukemia along with other way of life illnesses.
“We aim to bring Japan’s health screening culture to India,” says Masaharu Morita, worldwide promoting/new business enterprise manager, Modality Solution, Medical Division, Fujifilm. “We use AI for three important things: high quality, low invasive and speed. The AI technology is developed in Japan and it can detect the abnormality automatically and alert the doctors and radiologists. We are using ultra low radiation CT which is 1/50 of normal CT and it’s the same radiation dose as chest X-ray. AI technology enables us to sharpen the low-dose image that would be missed by the naked eye. We test for the 10 common cancers and lifestyle diseases critical illness such as chronic obstructive pulmonary disease, myocardial infarction and diabetic in 120 minutes.”
In addition to 10 cancer tests, the centre will provide total health-related examination services such as early detection of dangers of metabolic syndrome and locomotive syndrome, way of life-associated illnesses such as chronic obstructive pulmonary illness and myocardial infarction.
According to Morita, with enhanced life expectancy in India, there is a shift from communicable illnesses to non-communicable illnesses such as cancer, myocardial infarction and diabetes. These are curable if identified at an early stage but most of these illnesses are identified at a later stage in India so mortality price is higher, producing common well being screening essential. “We plan to open about 100 such centres in India starting with metro cities and then expanding across entire India,” he adds.